T cell manufacturing compositions and methods
US11162072B2 · kind B2 · utility
1Cited by
4References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 6, 2020 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Jan 6, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/1121
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.